Overview

FP-101 for the Treatment of Hot Flashes in Postmenopausal Women

Status:
Completed
Trial end date:
2018-10-29
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy of FP-101 versus placebo for the treatment of hot flashes in postmenopausal women.
Phase:
Phase 2
Details
Lead Sponsor:
Fervent Pharmaceuticals
Collaborators:
Iqvia Pty Ltd
QuintilesIMS